Histone proteins, including H3, are crucial for the organization of chromatin, which is the complex of DNA and protein found in eukaryotic cell nuclei. These proteins facilitate the packaging of DNA into a compact, regulated structure, allowing for efficient management of genetic information. The H3 histone, in particular, is a core component of the nucleosome, which serves as the fundamental unit of chromatin, aiding in the regulation of gene expression by controlling DNA accessibility. If H3H were a unique variant of histone H3, activators targeting this variant would interact with it in a way that could affect chromatin structure and function, potentially by altering the incorporation of H3H into nucleosomes, influencing post-translational modifications, or affecting the interaction with other histone proteins or chromatin remodeling factors.
The exploration of H3H activators would involve a multi-faceted research approach to understand their biochemical properties and the mechanisms by which they influence H3H function. Initial stages would include the synthesis and screening of a diverse chemical library to identify compounds that selectively bind to H3H. Techniques such as mass spectrometry, fluorescence resonance energy transfer (FRET), or yeast two-hybrid assays might be employed to detect and characterize interactions with H3H. Following identification, the binding dynamics of these activators with H3H could be assessed using biophysical methods such as isothermal titration calorimetry, surface plasmon resonance, or differential scanning calorimetry, which provide insights into the thermodynamics and kinetics of the interactions. Structural determination could be achieved through methods like X-ray crystallography or cryo-electron microscopy, offering a detailed view of how these activators engage with H3H at the atomic level. Complementary in vitro assays, including nucleosome assembly and chromatin remodeling assays, would be essential to discern how H3H activators affect nucleosome stability and the higher-order chromatin structure. Genome-wide analysis techniques, such as ChIP-seq or assay for transposase-accessible chromatin using sequencing (ATAC-seq), could reveal the distribution of H3H across the genome and how its activation by these compounds alters chromatin accessibility and gene expression patterns. Through these comprehensive investigations, the role of H3H activators in chromatin biology could be elucidated, broadening the understanding of epigenetic regulation.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A cytidine analog that inhibits DNA methyltransferase, potentially leading to demethylation and altered gene expression. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $53.00 $89.00 | 7 | |
Can inhibit acetaldehyde dehydrogenase and might influence acetylation patterns, thereby potentially affecting gene expression. | ||||||
Oxamflatin | 151720-43-3 | sc-205960 sc-205960A | 1 mg 5 mg | $151.00 $470.00 | 4 | |
An HDAC inhibitor that can alter histone acetylation states and possibly gene expression patterns. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
A selective HDAC inhibitor that could modulate chromatin structure and subsequently gene transcription. | ||||||
Anacardic Acid | 16611-84-0 | sc-202463 sc-202463A | 5 mg 25 mg | $102.00 $204.00 | 13 | |
An inhibitor of histone acetyltransferase and may alter histone acetylation and gene expression. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
A compound found in turmeric that can modulate various signaling pathways and potentially affect gene expression. | ||||||
Zebularine | 3690-10-6 | sc-203315 sc-203315A sc-203315B | 10 mg 25 mg 100 mg | $129.00 $284.00 $1004.00 | 3 | |
A DNA methyltransferase inhibitor that could lead to DNA demethylation and changes in gene expression. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
May influence histone deacetylases and potentially alter gene expression patterns through epigenetic mechanisms. | ||||||
Parthenolide | 20554-84-1 | sc-3523 sc-3523A | 50 mg 250 mg | $81.00 $306.00 | 32 | |
May affect NF-κB pathway and other signaling pathways, leading to changes in transcriptional regulation. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
A tyrosine kinase inhibitor that might influence signal transduction pathways and potentially affect gene expression. | ||||||